Cargando…
SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?
Background 21-hydroxylase-deficiency (21OHD) accounts for more than 95% of CAH cases. Serum 17-hydroxyprogesteron (17OHP) and androstenedione (A4) are traditional biomarkers for monitoring therapy. While generally there is good linear correlation between 17OHP and A4, physicians are likely to encoun...
Autores principales: | Jha, Smita, Turcu, Adina F, Sinaii, Ninet, Brookner, Brittany, Veeraraghavan, Padmasree, Mallappa, Ashwini, Auchus, Richard Joseph, Merke, Deborah P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207767/ http://dx.doi.org/10.1210/jendso/bvaa046.1756 |
Ejemplares similares
-
SUN-LB4 Androgenic Profiles of Patients With Severe Insulin Resistance
por: Jha, Smita, et al.
Publicado: (2020) -
MON-158 Rates of Illnesses in Patients with Congenital Adrenal Hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2020) -
Individualizing Management of Infertility in Classic Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumors
por: Jha, Smita, et al.
Publicado: (2019) -
RF10 | PMON221 11-Oxygenated-Androgens in Females with Severe Insulin Resistance
por: Merke, Deborah, et al.
Publicado: (2022) -
SUN-371 Successful Induction of Fertility with Low-Dose Dexamethasone in a Patient with Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumor
por: Jha, Smita, et al.
Publicado: (2019)